{"name":"Immutep Australia Pty. Ltd.","slug":"immutep-australia-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOTFNBZE5pMmk2YjJ0V0UzSVlXSVhFaFE1YW1IU215VHMxajRyQloyMngzYk1ENTkwdVBVeGdFbUo1ck5uend3Xzd1QmhmY1ZKVUo3ckJocjlSYWYxak1sNXpFMENxUF94c1hDc1gyb2drdWtQUjEweGZBVEFoMy05OWFDbWllckFnNl92MzRhRngxdFNNX2RsRGNEZjhLOGtQRlVDWG5YcEw?oc=5","date":"2026-04-08","type":"trial","source":"PharmaDispatch","summary":"Immutep reassesses and resets lead cancer program following trial setback - PharmaDispatch","headline":"Immutep reassesses and resets lead cancer program following trial setback","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-26","type":"earnings","source":"simplywall.st","summary":"Immutep H1 2026 Loss Worsening Challenges Bullish Revenue Growth Narratives - simplywall.st","headline":"Immutep H1 2026 Loss Worsening Challenges Bullish Revenue Growth Narratives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPU24tYU13TThlVllELUZBelpOWWpWdmN5bkt2R2laMjc0bjc5Q25SVVZGSlQ3X3cwTFRrUGUtVDJmOVdRbEZsNzFJTTAtenZHdEFIa3J5dGZ6TjVkRGVGM1F2Yk9XS0thMFVhU0M0RFNwXzhPWEI4MFRxYURnN1ZMS2h5WEh6a0dlZmhmY3NUXzVPbVVlV2xIQzlYaHJnRG1qaUVuNmFxUi1uQm8?oc=5","date":"2026-01-29","type":"earnings","source":"Stock Titan","summary":"Immutep (NASDAQ: IMMP) lands efti licensing deal and funds runway to Q2 2027 - Stock Titan","headline":"Immutep (NASDAQ: IMMP) lands efti licensing deal and funds runway to Q2 2027","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"trial","source":"simplywall.st","summary":"Immutep (ASX:IMM): Valuation Check After Dr. Reddy’s Licensing Deal and New Phase II Breast Cancer Data - simplywall.st","headline":"Immutep (ASX:IMM): Valuation Check After Dr. Reddy’s Licensing Deal and New Phase II Breast Cancer Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQUkVaNUtzTzZPU0RDZlN6dFJXWnF0QVhzTmpQNWJ1bGtNUUt4WEthWHdBUm1kcUJQVklDWTlNSGF3QzVPbFpXYzJ6enF0cTJDRTBwVVA2SkxpcVFDVXVoNFNJbFloNHJPQ0daekF5TFdiRG1RVHdiOElzTzJiRmU4bFhZWGJLQURfMjNDVVpDMkc2X0IxQWwtSWg2RUI2M3FtWUV6Qmo0dU5tZnBVZUhCYXZTN3M0aXgwR2JlS2x6VGx6WkdkVmhsQTcxNmRPVzBLOHlR?oc=5","date":"2025-12-08","type":"deal","source":"BioSpectrum Asia","summary":"Australia's Immutep inks oncology deal worth $349.5 M with Indian pharma firm Dr. Reddy's - BioSpectrum Asia","headline":"Australia's Immutep inks oncology deal worth $349.5 M with Indian pharma firm Dr. Reddy's","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-08","type":"pipeline","source":"Business Standard","summary":"Dr Reddy's signs licensing pact with Immutep to develop, market cancer drug - Business Standard","headline":"Dr Reddy's signs licensing pact with Immutep to develop, market cancer drug","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-08","type":"deal","source":"The Economic Times","summary":"Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug - The Economic Times","headline":"Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNemNNV2l3aW44dDRFWXJVU0JTZXVQQlVxQk00c25YWmlrWGR3X2pmdDR6UENDNHB2WURwU3A0eHdxSlZDeUVKSVoxOUtlUTBZQWN4RmZrSU1hLUFDSUdEc19IQkxKa3NTemhCQy1sOTJCRXY4bnV4SVloYThfUmx3Vzg0YlpPc2UtRXFLb1BjQWtoSGNf?oc=5","date":"2025-08-02","type":"pipeline","source":"BioSpectrum Asia","summary":"Australia searches for the next CSL - BioSpectrum Asia","headline":"Australia searches for the next CSL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE92X3locGdISjlreDlRMFZXc0dfWFdLMjVpcnc2cDgwa0x5WVdDUm1IcHNSUU12T2RUbVBSY3cxRGJyR0hRM00zR0FRQm1qQ1pWYm9F?oc=5","date":"2025-07-10","type":"pipeline","source":"FirstWord Pharma","summary":"FW In Conversation: Immutep CEO Marc Voigt on reinventing LAG-3 - FirstWord Pharma","headline":"FW In Conversation: Immutep CEO Marc Voigt on reinventing LAG-3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOZkxGeTB4VE0yZUF4MzRuZzRFR1NWQ2RlYUZ6UHBQVmxYN2ZrWXNWNl9Ma0dIOS1ianZlUHBnSVlvSzRTSi1WOHhoN3NxODk0b1BxYUdDbGoxSDlIcTdSM2VmdTYwcTQ2Y1EwRmZYNmZJMXNlbW41NDJaNl9Oc2puMzVmOE43LS12dEdWV1NFaVpKVy14NVZVQnE5NA?oc=5","date":"2025-05-08","type":"trial","source":"Seeking Alpha","summary":"Immutep Limited: Surging On Positive Head And Neck Data (NASDAQ:IMMP) - Seeking Alpha","headline":"Immutep Limited: Surging On Positive Head And Neck Data (NASDAQ:IMMP)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOclFscEJac1FFLWp4Zzc5d0RwcHY4LXMtZEpnUTdVSlIzTlI0YXM4c3lIbTR1clhyYmQ0aDhWUFo2ZEZlbE41WnZOSUFUcEN0bUE0bl9TRGZCWm5qWjhNam1remFURUhMX0ExTVNDRjJEZE45SjNHaDZlSFpkMFdVNnB1akZyZzY0TnY5UDdKRm9CS2dYTTNkYnZwODZIMG5yLWlpRm1FZmJLcllqUVV3X1JQdXdxWENUREE?oc=5","date":"2025-05-05","type":"trial","source":"Fierce Biotech","summary":"Immutep takes immunotherapy a step further with 'impressive' survival data from Keytruda combo - Fierce Biotech","headline":"Immutep takes immunotherapy a step further with 'impressive' survival data from Keytruda combo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSC05dXVnWU5iY1pndVhLYkM0MXlDaFc0c1JVY2R1MjRCRFNQdkdvbVZRT0tGRjF3RjdubVRBX19QbzJFSDkzT1hTSFh6Uk1tWHVmTUVDbTJQOUFwOEd0VnVkRmpURW0tVUdRMlY1NUp0dDNRdkZjTTEwZTdPMjc2ZElRMm9sLXM?oc=5","date":"2024-07-14","type":"trial","source":"pharmaphorum","summary":"Immutep mulls filings for LAG-3 drug after new readout - pharmaphorum","headline":"Immutep mulls filings for LAG-3 drug after new readout","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}